ZebraMed
Évry-Courcouronnes, France
Pharma is blind to systemic human response, losing $100B annually and seeing 25% of new drugs receive black-box warnings for unforeseen toxicity. ZebraMed delivers systemic insight, cutting target-to-IND time by 50% and discovering targets based on human systemic response. Our Bio/AI OS industrializes multimodal zebrafish–human data to map mechanisms across diseases: 2x closer to human, interpretable AI (FDA/EMA-grade), with Tier 1 pharma traction and in vivo risk reduction.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2025
- Website
- www.zebramed.bio
Only accessible to MedStartr community members.
Join nowWhat do you think of ZebraMed?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now